Latest News

Home testing devices could monitor epilepsy, drug levels, reduce clinical visits

Medications remain the mainstay of epilepsy treatment, and to date there are no FDA-approved devices that provide an accurate means of detection for generalized tonic-clonic seizures (GTCS), or convulsions, during activities of daily living. Two new studies provide data that warrants the development of non-invasive devices with the capability to signal the onset of an epileptic seizure and could be crucial to optimal patient dosing.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Universal helmet laws reduce traumatic brain injuries in young motorcyclists, according to trauma surgeons

  • Potential treatment target for cocaine addiction identified by study

  • New discovery could lead to more targeted head and neck cancer therapies

  • New molecule sneaks medicines across blood-brain barrier

  • One hormone, Two roles: Sugars differentiate seasonality, metabolism

  • For stroke patients, hospital bed position is delicate balancing act

  • Novel tinnitus therapy helps patients cope with phantom noise

  • People change their moral values to benefit themselves over others

  • Digital Therapist: Computer program analyzes speech, mental health

  • High prevalence of vitamin D deficiency across the board in neuromuscular disease

  •